In late 2014, the FDA approved Soolantra, a topical cream, for the treatment of acne rosacea associated with demodex mites. Ivermectin, the active ingredient in the cream, has both anti-inflammatory and antiparasitic activity. The basis for the cream is Cetaphil moisturizing cream.
An ophthalmic version has not yet been approved in the United States.
Continue to view the FDA announcement
Reference
An emerging treatment: topical Ivermectin for papulopustular rosacea
Abokwidir M, Fleischer AB.
The Journal of Dermatological Treatment
2015;26(4):379-80. doi: 10.3109/09546634.2014.991672. Epub 2015 Jan 30.
View the full report